Cargando…

Hallmarks of Splicing Defects in Cancer: Clinical Applications in the Era of Personalized Medicine

Alternative splicing promotes proteome diversity by using limited number of genes, a key control point of gene expression. Splicing is carried out by large macromolecular machineries, called spliceosome, composed of small RNAs and proteins. Alternative splicing is regulated by splicing regulatory ci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rahman, Mohammad Alinoor, Nasrin, Farhana, Bhattacharjee, Sonali, Nandi, Saikat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352608/ https://www.ncbi.nlm.nih.gov/pubmed/32481522 http://dx.doi.org/10.3390/cancers12061381

Ejemplares similares

Rare Genetic Diseases with Defects in DNA Repair: Opportunities and Challenges in Orphan Drug Development for Targeted Cancer Therapy
por: Bhattacharjee, Sonali, et al.
Publicado: (2018)

Competitive regulation of alternative splicing and alternative polyadenylation by hnRNP H and CstF64 determines acetylcholinesterase isoforms
por: Nazim, Mohammad, et al.
Publicado: (2017)

SRSF1 and hnRNP H antagonistically regulate splicing of COLQ exon 16 in a congenital myasthenic syndrome
por: Rahman, Mohammad Alinoor, et al.
Publicado: (2015)

Combination therapy to checkmate Glioblastoma: clinical challenges and advances
por: Ghosh, Debarati, et al.
Publicado: (2018)

Choices have consequences: the nexus between DNA repair pathways and genomic instability in cancer
por: Bhattacharjee, Sonali, et al.
Publicado: (2016)

DNA damage response and cancer therapeutics through the lens of the Fanconi Anemia DNA repair pathway
por: Bhattacharjee, Sonali, et al.
Publicado: (2017)

Splicing regulation of GFPT1 muscle-specific isoform and its roles in glucose metabolisms and neuromuscular junction
por: Farshadyeganeh, Paniz, et al.
Publicado: (2023)

HnRNP C, YB-1 and hnRNP L coordinately enhance skipping of human MUSK exon 10 to generate a Wnt-insensitive MuSK isoform
por: Nasrin, Farhana, et al.
Publicado: (2014)

RNA Splicing in Cancer and Targeted Therapies
por: Islam, Md Rafikul, et al.
Publicado: (2023)

Aberrant Alternative Splicing Is Another Hallmark of Cancer
por: Ladomery, Michael
Publicado: (2013)

Recurrent SRSF2 mutations in MDS affect both splicing and NMD
por: Rahman, Mohammad Alinoor, et al.
Publicado: (2020)

Metabolomics of infectious diseases in the era of personalized medicine
por: Rahman, Mahbuba, et al.
Publicado: (2023)

Hallmarks of a new era in mitochondrial biochemistry
por: Pagliarini, David J., et al.
Publicado: (2013)

CRISPR–Cas9 a boon or bane: the bumpy road ahead to cancer therapeutics
por: Ghosh, Debarati, et al.
Publicado: (2019)

Transcription Factors That Govern Development and Disease: An Achilles Heel in Cancer
por: Huilgol, Dhananjay, et al.
Publicado: (2019)

The biology of personalized cancer medicine: Facing individual complexities underlying hallmark capabilities
por: De Palma, Michele, et al.
Publicado: (2012)

Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer
por: Farina, Antonietta Rosella, et al.
Publicado: (2020)

Splicing regulatory factors in breast cancer hallmarks and disease progression
por: Koedoot, Esmee, et al.
Publicado: (2019)

Mechanism of Nonsense-Mediated mRNA Decay Stimulation by Splicing Factor SRSF1
por: Aznarez, Isabel, et al.
Publicado: (2018)

Magnetic Resonance Imaging and Iron-oxide Nanoparticles in the era of Personalized Medicine
por: Rahman, Mahbuba
Publicado: (2023)

Education for all in the era of personalized medicine
por: Özgüç, Meral
Publicado: (2014)

Genetics and Vaccines in the Era of Personalized Medicine
por: Castiblanco, John, et al.
Publicado: (2015)

Molecular Imaging in the Era of Personalized Medicine
por: Jung, Kyung-Ho, et al.
Publicado: (2015)

Allergic Asthma in the Era of Personalized Medicine
por: Papapostolou, Niki, et al.
Publicado: (2022)

Asthma Phenotypes in the Era of Personalized Medicine
por: Gonzalez-Uribe, Victor, et al.
Publicado: (2023)

Hallmarks of cancer and hallmarks of aging
por: Blagosklonny, Mikhail V.
Publicado: (2022)

Defective apical extrusion signaling contributes to aggressive tumor hallmarks
por: Gu, Yapeng, et al.
Publicado: (2015)

SRSF1 suppresses selection of intron-distal 5′ splice site of DOK7 intron 4 to generate functional full-length Dok-7 protein
por: Ahsan, Khalid Bin, et al.
Publicado: (2017)

HnRNP L and hnRNP LL antagonistically modulate PTB-mediated splicing suppression of CHRNA1 pre-mRNA
por: Rahman, Mohammad Alinoor, et al.
Publicado: (2013)

Assessment of Both Personal and Professional Aspects to Measure Job Satisfaction Levels among Garment Workers: Empirical Evidence from a Developing Country
por: Yuan, Deli, et al.
Publicado: (2022)

Splice-switching of the insulin receptor pre-mRNA alleviates tumorigenic hallmarks in rhabdomyosarcoma
por: Khurshid, Safiya, et al.
Publicado: (2022)

Personalized medicine: An era of dosage form development
por: Nagaich, Upendra
Publicado: (2017)

Emerging Biomarkers in the Era of Personalized Cancer Medicine
por: Ricciuti, Biagio, et al.
Publicado: (2019)

Chemotherapy for Lung Cancer in the Era of Personalized Medicine
por: Lee, Seung Hyeun
Publicado: (2019)

Colorectal Cancer Biomarkers in the Era of Personalized Medicine
por: Patel, Jai N., et al.
Publicado: (2019)

Chemistry of Fluorinated Pyrimidines in the Era of Personalized Medicine
por: Gmeiner, William H.
Publicado: (2020)

Personalized Nursing Care in Precision-Medicine Era
por: Lopes-Júnior, Luís Carlos
Publicado: (2021)

Ethical implications of epigenetics in the era of personalized medicine
por: Santaló, Josep, et al.
Publicado: (2022)

Multidisciplinary amyloidosis care in the era of personalized medicine
por: Bumma, Naresh, et al.
Publicado: (2022)

Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome
por: Madan, Vikas, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4r68gfmav3htt3npdu1b76pr4o